Multiple Myeloma
Featured Articles
(New York Times) Apr 19, 2018 - The promise of new treatments like immunotherapies have blurred the line between cure and comfort — and between hope and hopelessness — disrupting the fragile equilibrium that we doctors have long taken for granted.
Read Article
(bluebird bio) Mar 28, 2018 - bluebird bio, Inc. and Celgene Corporation today announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy for the potential treatment of patients with...
Read Article
Latest Articles
April 20, 2018
April 18, 2018
April 16, 2018
April 13, 2018
April 12, 2018
April 10, 2018
April 09, 2018
March 27, 2018
View More
News Commentary
Editor Image
16 Jun, 2017 | by Winston Wong, PharmD
This sounds like the same play innovator manufacturers are playing in the...
View Comment
Editor Image
02 Jan, 2018 | by Winston Wong, PharmD
These 7 Key Trends are definitely a continuation of what we have seen through...
View Comment
View More
OBR Green
There are no Multiple Myeloma OBR Green articles.
OBR Blog
There are no Multiple Myeloma blog entries.